Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.
暂无分享,去创建一个
M. Martinez-Alonso | J. Garnacho-Montero | M. Sánchez-García | Francisco J. Lozano‐García | M. Palomar-Martínez | J. Aranaz-Andres | F. Barcenilla-Gaite | M. Catalán-González | P. Ramírez-Galleymore | F. Álvarez-lerma | Rosa García | J. Álvarez | I. Fernández-Moreno
[1] M. Kempf,et al. High prevalence of contamination of sink drains with carbapenemase-producing Enterobacteriaceae in 4 intensive care units apart from any epidemic context. , 2020, American journal of infection control.
[2] Joan M. Lynch,et al. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis , 2018, BMC Infectious Diseases.
[3] M. Martinez-Alonso,et al. A Before-and-After Study of the Effectiveness of an Antimicrobial Stewardship Program in Critical Care , 2018, Antimicrobial Agents and Chemotherapy.
[4] M. Poljak,et al. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance , 2018, Intensive Care Medicine.
[5] J. Iredell,et al. Antibiotic Cycling and Antibiotic Mixing: Which One Best Mitigates Antibiotic Resistance? , 2017, Molecular biology and evolution.
[6] K. Hillman,et al. Chlorhexidine bathing and health care-associated infections among adult intensive care patients: a systematic review and meta-analysis , 2016, Critical Care.
[7] S. Blot,et al. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] C. Hertogh,et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.
[9] J. Campos,et al. Combatting resistance in intensive care: the multimodal approach of the Spanish ICU “Zero Resistance” program , 2015, Critical Care.
[10] F. Gordo,et al. Guidelines for the prevention of ventilator-associated pneumonia and their implementation. The Spanish "Zero-VAP" bundle. , 2014, Medicina intensiva.
[11] Ronald N. Jones,et al. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). , 2014, Diagnostic microbiology and infectious disease.
[12] S. Arakawa,et al. Impact of pre-emptive contact precautions for outborn neonates on the incidence of healthcare-associated meticillin-resistant Staphylococcus aureus transmission in a Japanese neonatal intensive care unit. , 2013, The Journal of hospital infection.
[13] A. Oliver,et al. [Programs for optimizing the use of antibiotics (PROA) in Spanish hospitals: GEIH-SEIMC, SEFH and SEMPSPH consensus document]. , 2012, Enfermedades infecciosas y microbiologia clinica.
[14] Dirk Vogelaers,et al. The rising problem of antimicrobial resistance in the intensive care unit , 2011, Annals of intensive care.
[15] G. B. Orsi,et al. Surveillance and management of multidrug-resistant microorganisms , 2011, Expert review of anti-infective therapy.
[16] O. Tasaki,et al. Pre-emptive contact precautions for intubated patients reduced healthcare-associated meticillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit , 2011, Journal of Hospital Infection.
[17] H. Fraimow,et al. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens. , 2011, Critical care clinics.
[18] Jordi Rello,et al. International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.
[19] Alex van Belkum,et al. 5 Years of Experience Implementing a Methicillin-Resistant Staphylococcus aureus Search and Destroy Policy at the Largest University Medical Center in the Netherlands , 2009, Infection Control & Hospital Epidemiology.
[20] M. Gourlay,et al. The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] F. Álvarez-Lerma,et al. Vigilancia y control de Staphylococcus aureus resistente a meticilina en hospitales españoles. Documento de consenso GEIH-SEIMC y SEMPSPH , 2008 .
[22] J. Beaumont,et al. Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals , 2008, Annals of Internal Medicine.
[23] D. Maki,et al. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. , 2006, American journal of infection control.
[24] C. Masuet,et al. Comparative Cost of Selective Screening To Prevent Transmission of Methicillin-Resistant Staphylococcus aureus (MRSA), Compared With the Attributable Costs of MRSA Infection , 2006, Infection Control & Hospital Epidemiology.
[25] Stephan Harbarth,et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study , 2006, Critical care.
[26] S. Cosgrove. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[27] S. Michie,et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.
[28] S. Swidsinski,et al. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[29] S. Chevret,et al. Prevalence and Risk Factors for Carriage of Methicillin-Resistant Staphylococcus aureus at Admission to the Intensive Care Unit , 2016 .
[30] A. Troelstra,et al. Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year Survey , 2002, European Journal of Clinical Microbiology and Infectious Diseases.